Abstract:Background: Glucocorticoid plays an important role in the control of carbohydrate metabolism. Patients with Cushing's syndrome have been reported to have an increased incidence of carbohydrate intolerance due to peripheral insulin resistance and hyperinsulinernia, although the exact incidence and nature of this disorder have remained unclear. Few results have been published about insulin resistance and insulin secretion according to the level of glucose concentration, or about the reversibility of such defects in patients with Cushing's syndrome. Methods: To assess the effect of glucocorticoid on the insulin sensitivity and insulin secretion in Cushing's syndrome, 15 patients with Cushing's syndrome were classified into 3 groups (normal glucose tolerance: NGT, impaired glucose tolerance: lGT, diabetes: DM) according to the degree of glucose tolerance based on the oral glucose tolerance test (DGIT). Insulin modified, frequently sampled, intravenous glucose tolerance test (FSlGT) was performed before and after curative surgery on these patients and on 15 healthy control subjects. Data were evaluated by non-parametric statistical analysis. Results: 1) Amoug the 15 patieuts with Cushiug's syudrome, 3 (20%) were NGT, 4 (27%) IGT, and 8 (53%) DM, based on OGTT. Twenty-four hour urinary free cortisol (UFC) was significantly higher in the DM group. 2) Insulin sensitivity index (SI) of Cushing's syndrome was significantly lower than that of the control group (P=0.0024), but was not significantly different among the three Cushing's syudrome groups of NGT, IGT and DM. 3) Glucose mediated glucose disposal (SG) (Edconfirm this abbreviation; it does not seem to match the definition) of Cushing's syndrome was not significantly different from that of the control group. 4) Insulin secretion (AIRg) of Cushing's syndrome tended to be high, but it was not significantly different from that of control. However, according to the level of glucose concentration there was significant difference in AlRg among the three Cushing's syndrome groups (P=0.003l); AIRg of DM was significantly lower than that of NGT. 5) After surgical treatment, parameters of insulin sensitivity and insulin secretion were normalized in 6 cured patients; 1 with NGT, 1 with IGT, and 4 with DM, preoperatively. Median Sl of all 6 patients was significantly improved up to the normal range postoperatively (P=0.0022). Median AIRg of these 6 patients was balanced around that of normal control postoperatively (P=0.0286). Conclusion: Eighty percent of patients with Cushing's syndrome had abnormality of carbohydrate metabolism. Insulin sensitivity was significantly decreased in Cushing's syndrome. Insulin secretion was significantly higher only in the NGT and lGT groups of Cushing's syndrome. As the hypercortisolemia is exacerbated, insulin secretion is significantly decreased and causes DM, suggesting that glucocorticoid has a direct or indirect toxic effect on the pancreatic beta cell.

The Change of Insulin Sensitivity and Insulin Secretion According to Glucose Metabolism Status in Patients with Cushing's Syndrome

Related Risk Factors of Abnormal Glucose Metabolism in Patients with Cushing's Disease

Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.

Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study

[Clinical Features and Outcomes of Surgical Versus Conservative Management in Patients with Subclinical Cushing's Syndrome].

SAT-370 Clinical Characteristics and Metabolic Features of Patients with Subclinical Cushing's Syndrome and Its Correlation with Cortisol Level

Metabolic Syndrome in Subclinical Cushing’s Syndrome of Adrenal Incidentaloma

Biochemical Control in Cushing's Syndrome: Outcomes of the Treatment in a Large Single Center Cohort

Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism

Insulin sensitivity and first-phase insulin secretion in obese subjects with impaired glucose regulation in Shanghai

Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases

[A Study of the Degrees of Insulin Resistance and First-Phase Insulin Secretion of Beta-Cells in Metabolic Syndrome Patients with Different Glucose Tolerance].

Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing's syndrome

Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance

Differences in Insulin Resistance and Pancreatic B‐cell Function in Obese Subjects with Isolated Impaired Glucose Tolerance and Isolated Impaired Fasting Glucose

Cushing Syndrome: A Review

Characteristics of Glucose Metabolism in Patients with Pituitary Growth Hormone Secreting Adenomas and the Impact of Trans?sphenoid Surgery

The Immune System in Cushing's Syndrome

Relationship Between Secretion of Cortisol and Higher Blood Glucose in Patients with Diabetes Mellitus

Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance?

Insulin resistance in endocrine disorders - treatment options